Polaryx Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2014-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.polaryx.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3
Phase 3
Not yet recruiting
- Conditions
- Juvenile Neuronal Ceroid Lipofuscinosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-11-19
- Last Posted Date
- 2025-05-30
- Lead Sponsor
- Polaryx Therapeutics, Inc.
- Target Recruit Count
- 39
- Registration Number
- NCT04637282
News
No news found